Calpastatin is a specific inhibitor of the calpains. Calpains play a key role in postmortem tenderization of meat and have been hypothesized to be involved in muscle protein degradation in living tissue. Isolation, cloning of complementary DNA, and nucleotide sequencing of bovine calpastatin from the longissimus muscle have been completed. Two clones were identified that encompass the entire coding sequence. Clone pCR41, derived by reverse transcription-PCR, covers domains L and 1; clone pBSA1, obtained from cDNA library screening, covers domains 2 through 4 in addition t o the 3'-nontranslated region. Nucleotide sequence analysis of the cDNA for bovine calpastatin revealed an average nucleotide sequence identity of approximately 70 to 80% compared with published calpastatin nucleotide sequences of human, rabbit, and pig. Exon 3, corresponding to a highly conserved 22-amino acid region, was deleted from bovine calpastatin domain L. The calculated molecular weight of bovine skeletal muscle calpastatin of 706 amino acid residues ( M r 75,842) corresponds to the value of purified bovine skeletal muscle calpastatin as determined by SDS-PAGE (Mr 68,000). Northern blot analysis revealed the presence of multiple calpastatin mRNA transcripts having estimated sizes of 3.8, 3.0, and 1.5 kb in beef and 3.8, 3.0, 2.5, and 1.5 kb in sheep. Calpastatin mRNA expression was increased with &adrenergic agonist-induced muscle hypertrophy.
Introduction
The calcium-dependent proteolytic system (calpains) is considered to be one of the major cytosolic proteolytic systems. Calpains have been hypothesized t o be involved in a variety of cellular processes (for review see Croall and DeMartino, 1991) . In living muscle, the calpains are considered to be the primary candidate for initiating the degradation of myofibrillar proteins (for review see Go11 et al., 1992) . Current 'Names are necessary to report factually on the available data; however, the USDA neither guarantees nor warrants the standard of the product, and the use of the name by USDA implies no approval of the product to the exclusion of others that may also be J. Anim. Sci. 1994. 72:606-614 evidence suggests that in postmortem tissue the calpains are responsible for proteolysis of those myofibrillar proteins whose degradation causes the weakening of the myofibrillar structure and, therefore, meat tenderization (for review see Koohmaraie, 1992a,b,c; Koohamaraie et al., 1993) .
Calpastatin is an endogenous inhibitor of the calpains (EC 3.4.22.17, Ca2+-dependent cysteine proteinase) inhibiting both forms of calpains (lowcalcium-requiring form called p-calpain and a highcalcium-requiring form called m-calpain). Calpastatin is, therefore, considered to be one of the major modulators of the calpains. Some studies have reported that in living muscle, when protein degradation is reduced, the activity of calpastatin is increased (Wheeler and Koohmaraie, 1992; Morgan et al., 1993) . Additionally, there is ample evidence to suggest that calpastatin is a principal regulator of the calpains in postmortem proteolysis (for review see Koohmaraie et al., 1994) . Because of these significant functions of calpastatin and because its sequence in suitable.
skeletal muscle has not been determined, the objective of the present work was to clone and sequence the bovine skeletal muscle calpastatin and examine the steady-state expression of its messenger RNA in beef
Materials and Methods
Tissue for cDNA Library Preparation. Muscle samples were collected from the longissimus muscle (LM) of a steer at the 12th-13th rib interface within 20 min of exsanguination. Muscle tissue was trimmed of fat, minced, rapidly frozen by immersion in liquid nitrogen, and stored at -70°C until it was processed.
R N A Preparation. Total muscle cellular RNA was isolated from 10 g of frozen sample according to the method of Chomczynski and Sacchi (1987) . Total RNA was quantified by reading its absorbance at 260 nm and then stored at -80°C. Poly (A+) RNA was isolated from muscle total RNA by oligo (dT)-cellulose chromatography as described by Aviv and Leder (1972) using two passages through separate l-mL columns. The poly (A+) RNA was quantified and stored as described above.
cDNA Synthesis and Library Construction. A cDNA library representing the bovine LM poly (A+) RNA was constructed using 5 pg of poly (A+) RNA in the Uni-ZAPTM XR cloning vector as described by the manufacturer (Stratagene, La Jolla, CAI. Synthesized cDNA were size-fractionated on a Sepharose CL-4B column and larger cDNA populations (> 700 bp) were pooled. The cDNA was unidirectionally ligated into the Uni-ZAPTM XR vector arms, packaged in vitro, and amplified in the PLK-F' (mcrA-, mcrB-) host strain.
Screening of cDNA Library. Approximately 5 x lo6 recombinant phage were plated on 150-mm NZ-yeast broth (NZY) plates ( 5 x lo3 plaque-forming units[pful/plate) with liquid broth (LB) top agar. Plates were incubated overnight at 37°C and then placed at 4°C for 4 h. Replicate plaque lifts were made, denatured, and UV-crosslinked (1,200 pJ/cm2) to nylon membranes (MagnaGraph, Micron Separations, Westboro, MA). Membranes from each replicate lift were probed into 32P-labeled random primed cDNA probes to rabbit calpastatin ( hC1-21 and hC1-413; Emori et al., 1987 ; a generous gift to M. K. from Y. Emori) labeled to a specific activity of 1 x lo9 cpndpg of cDNA. Prehybridization and hybridization solutions consisted of 50% deionized formamide, 5x SSC ( l x SSC is 150 mM NaC1, 15 mM sodium citrate, pH 7.01, l x PE (50 mM Tris-HC1, pH 7.5; .l% wthol sodium pyrophosphate; 1% SDS; .2% polyvinylpyrolidone; .2% ficoll; 5 mM EDTA), and 150 pg/mL of denatured salmon sperm DNA. Membranes were prehybridized at 42°C for 3 h and then hybridized overnight at 42°C in fresh hybridization solution containing cDNA probes. Fifteen-minute membrane washes were performed at 65°C with two washes in 2x SSC, .l% SDS and two washes in .lx SSC, .l% SDS. Membranes were air-dried and positive signals visualized on Kodak X-OMATTM-AR film exposed overnight at -70°C. Clones giving positive signals were plaquepurified and rescreened two additional times to eliminate false positives.
Conversion of ssDNA Phage into dsDNA Plasmid. The Uni-ZAPTM XR cDNA phage clones were converted into respective pBluescript plasmid counterparts by in vivo excision according to the manufacturer's protocols to produce double-stranded DNA pBluescript plasmids containing cDNA inserts. Double-stranded replicative DNA was isolated from host bacteria and the cDNA insert excised by double digestion of the plasmid with XhoI and EcoRI restriction enzymes. Complete digestion of pBluescript DNA was confirmed by agarose gel electrophoresis and positive calpastatin pBluescript clones were reconfirmed by screening dot blots (Sambrook et al., 1989) with 32P-labeled random primed rabbit cDNA (1C1-21 and 1C1-413) probes.
Nucleotide Sequencing of Bovine Calpastatin.
Nucleotide sequencing was performed on doublestranded plasmid DNA according to the method of Sanger as described in the procedures provided with Sequenase Version 2.0 (United States Biochemicals, Cleveland, OH). Initial sequence data were generated using the forward and reverse M13 sequencing primers. Additional sequencing primers were designed from the derived nucleotide sequence until both strands were completely sequenced. Comparison and manipulation of bovine calpastatin sequence data were performed with the aid of the GCG program (Devereux et al., 1984 The reaction was performed at 37°C for 1 h followed by heating to 95°C for 5 min and centrifugation at 14,000 x g for 5 min. Tne resultant supernatant was used as cDNA template for PCR amplification. The PCR was carried out in a MJ Research Thermal Cycler (Watertown, MA) using the following conditions: P1-and P2-primed PCR was repeated for 30 cycles with a single initial denaturation at 94°C for 2 min followed by cycling conditions of 94°C for 1 min, annealing at 54°C for 1 min, and extension at 72°C for 2 min in a volume of 50 pL. Reaction mixture concentrations were 50 mM KCI, 10 mM Tris-HC1 (pH 9.0), 1.5 mM MgC12, .01% gelatin (wt/vol), .l% Triton X-100, .2 mM each dNTP, 1.0 pM each primer, and 2.5 P2, (GA) 10 ACTAGTCTCGAGAGTTCTGATTCACT-pg of reverse transcription product. Ethidium bromidestained DNA fragments were visualized on 1% agarose gels. Wheeler and Koohmaraie (1992) . Sixteen crossbred wether lambs (1/2 Finnsheep, 1/4 Dorset, 1/4 Rambouillet), all within 2 wk of age, were randomly assigned to either control (18% CP) or BAA ( 4 ppm L644,969) treatment groups for 6 wk. For results of growth, endogenous proteinase activities, and postmortem proteolysis, see Koohmaraie et al. ( 199 1 ) .
Cloning

RNA Isolation and Northern and Slot Blot Analysis.
Muscle samples were removed from LM and stored as described before. Isolation of total RNA and poly(A+) RNA were performed as described earlier. Northern blot analysis and slot blot analysis were done according to Sambrook et al. (1989) as described previously (Koohmaraie et al., 1991) . 32P random-primed cDNA probes used in calpastatin message analysis were derived from excised cDNA inserts encoding bovine calpastatin domains L-1 (clone pCR41) or domains 2 to 4 including the 3' non-coding region (clone pBSA1).
Statis tical Analysis.
Data were analyzed by analysis of variance for a completely randomized design to test the effect of BAA treatment with the GLM procedures of SAS (1985) . Data from beef and lamb studies were analyzed separately.
Results and Discussion
Identification and Isolation of Bovine Clones for
Calpastatin. A cDNA library was produced representing the mRNA from bovine LM. Two cDNA clones developed to rabbit heart calpastatin were used as probes for screening the bovine cDNA library. Screening at a high stringency using rabbit calpastatin cDNA as a probe failed to detect any calpastatin-containing clones in the bovine skeletal muscle cDNA library, suggesting that there is some divergence in DNA sequence among calpastatins KOOHMARAIE from different species Tankano et al., 1988; Asada et al., 1989; Maki et al., 1991) . Variation in calpastatin primary sequence among species is further supported by the low level of hybridization of rabbit cDNA probes to bovine LM RNA upon Northern blot analysis (data not shown).
Approximately 5 x lo6 plaques of the bovine cDNA library were screened, resulting in numerous false positives as determined by dot blotting and sequencing. Careful attention to hybridization conditions and washing stringencies resulted in three clones that could be identified as containing the bovine calpastatin sequence. From restriction enzyme digestion determination of insert cDNA size, a single clone containing a cDNA insert of approximately 2.2 kb was isolated (clone pBSA1, accession no. L14450) and used in subsequent studies. Nucleotide sequencing strategy is shown in Figure 1 . Nucleotide sequencing and database comparisons of pBSAl verified that a bovine calpastatin cDNA clone had been isolated. Sequence analysis also indicated that pBSAl contained only domains 2 through 4 and the 3'-nontranslated region, and that the 5'-end of bovine calpastatin was not contained in pBSA1. The lack of domains L and 1 suggested that either bovine LM messenger RNA calpastatin is truncated as in anucleated erythrocytes (Maki et al., 1991) or that pBSAl contained only a portion of the full length message. A RT-PCR strategy was devised and implemented that used a degenerate universal calpastatin primer, P1, located upstream of the expected translational start site and a second primer, P2, designed to elucidate the bovine sequence contained at the border of domains 1 and 2 ( Figure  1 ). Analysis of RT-PCR products on 1% agarose gels (Lee et al., 1992b) . The significance of this deletion has not been ascertained, but it is speculated that deletions t -27 -9
7 8 26 and modifications to domain L may affect the calpain inhibitory activity of calpastatin. Modifications to calpastatin domain L may impart tissue specificity, cellular localization, and responsiveness to specific physiological conditions, as suggested by the truncated forms found in erythrocytes (Maki et al., 1991) and the multiple forms found in the rat (Lee et al., 1992a) . The recent reporting of the binding of calpastatin to membranes (Mellgren et al., 1989; Adachi et al., 1991) also suggested the involvement of domain L in this process. Taken together, the presence of multiple calpastatin transcript forms may suggest variations in the selection of inhibitory sites for calpain, which has also been shown to bind to membranes (Lee et al. 1990; Suzuki and Ohno, 1990) .
Deletions contained in domain L evidently are not responsible for all the observed differences in calpastatin mRNA transcript length, but they may have an effect on post-transcriptional and(or) translational modifications of the message or product. Evidence of such processes was previously demonstrated by Emori et al. (1987) , who showed that the actual aminoterminal amino acids of purified rabbit calpastatin were coded for in the mRNA beginning at residue 240, KOOHMARAJE suggesting that an N-terminal80 amino acid sequence from domain L is cleaved from calpastatin either before or after the translational process.
Analysis of Amino Acid Composition.
Comparison of the amino acid compositions of bovine skeletal muscle calpastatin with that of bovine cardiac calpastatin (Otsuka and Goll, 1987) and that derived from other species (Ishiura et al., 1982; Takano and Murachi, 1982; Emori et al., 1987; Takano et al., 1988) revealed that substantial differences can be present in the relative levels of many amino acids, whereas the levels for tryptophan, methionine, cysteine, and phenylalanine were consistently low ( Table  1 ). The calculated isoelectric point of 4.75 for bovine calpastatin agrees well with the estimated isoelectric point value of 4.85 to 4.95 for bovine cardiac calpastatin (Otsuka and Goll, 1987) .
Northern Blot Analysis. When probed with cDNA from the pBSAl clone, skeletal muscle calpastatin mRNA is present as three isoforms (3.8, 3.0, and 1.5 kb) in beef and four isoforms (3.8, 3.0, 2.5, and 1.5 kb) in sheep (Figure 3) . The predominance of each isoform varies. In beef the 3.0, and in sheep the 3.8, isoform is the most predominant message, as verified aValues expressed are the actual number of each amino acid for bovine skeletal muscle calpastatin as predicted by the coding region bExpressed as residuesi1,OOO. 'From Otsuka and Go11 (1987) expressed as residues/1,000. dFrom Ishiura et al. (1982) expressed as residues/1,000. eFrom Takano and Murachi (1982) expressed as residues/1,000. fFrom Takano et al. (1988) expressed as residues/1,000. gFrom Emori et al. (1987) expressed as residued1,OOO.
hhdicates the sum of Glu + Gln. !Indicates the sum of Asp + Asn.
JNot determined.
cDNA.
by densitometric analysis of Northern blots (data not shown). Probing with a cDNA insert derived from domains L and 1 (clone pCR41) confirmed the observed banding patterns. The beef pattern and isoform sizes are in agreement with the values reported for rabbit calpastatin isoforms . Variation in calpastatin transcript length may be the result of alternate polyadenylation sites and(or) differences in exon splicing (Lee et al., 1992b) in the protein coding region.
Comparisons with Other Calpastatins. A broad range of molecular weights were previously reported for purified calpastatin (from Mr of 68,000 to 170,000) as determined by SDS-PAGE mobility (Otsuka and The blot was hybridized to a radiolabeled bovine calpastatin cDNA probe encoding domains 2 through 4 plus the 3'-nontranslated region. To compensate for the greater bovine calpastatin signal strengths on the autoradiographs, exposure times were 18 h at -70°C and 6 h at -70°C for lamb and beef samples, respectively. Goll, 1987; Takano et al., 1988; Kendall et al., 1993) . The anomalies observed in determination of calpastatin molecular weight have been attributed t o posttranslational modifications and(or1 proteolytic cleavage encountered during purification (Goll et al., 1989) . The nucleic acid sequence of bovine calpastatin cDNA encodes a 706-amino acid protein with a predicted M , of 75,842. Although difflculty has been encountered in the determination of the amino terminal residues of calpastatin, calpastatin has been shown to be truncated at the amino terminal end when isolated from its native state (Maki et al., 1991) . Determined positions of truncation range from amino acid residue 2 for bovine heart (Mellgren et al., 19891 , position 80 for rabbit liver (Emori et al., 19871 , and position 290 for anucleated erythrocytes . The amino terminal residues of bovine skeletal muscle calpastatin have yet t o be determined. It is interesting to speculate that the occurrence and(or) position of truncation may have an effect on the calpain inhibitory activity of calpastatin.
Lengths of encoded amino acid chains for muscle calpastatins as derived from cloned cDNAs vary slightly, ranging from 718 in rabbit (Asada et al., 1989) t o 713 for porcine cardiac to 706 in bovine skeletal muscle. Comparison of the amino acid composition deduced from the cDNA for bovine skeletal muscle calpastatin with that obtained from the amino acid analysis of purified bovine cardiac calpastatin (Otsuka and Goll, 1987) indicates a very high degree of agreement (Table 1) . It was observed that none of the reported cDNAs nor the amino acid analyses of the purified calpastatin indicated the presence of tryptophan. Furthermore, calpastatins all possessed consistently low levels of phenylalanine, methionine, and cysteine amino acid residues. All other amino acids seem to have greater degrees of variability associated with their relative levels. As reported by Otsuka and Go11 (1987) , the low levels of tryptophan and phenylalanine support the finding of very low A280 values for purified calpastatin. The relatively conserved low levels of methionine and cysteine (the sulphur-containing amino acids) in calpastatin may suggest the importance of these residues in calpastatin activity, possibly through involvement in secondary structure and disulfide bridge formation. The hydrophilic nature of the amino acids that compose calpastatin is in agreement with the proposed and demonstrated predominance of calpastatin in the cytosolic fraction of the cell (Lee et al., 1990; Mellgren and Richard, 1990; Suzuki and Ohno, 1990) . The hydrophilic nature of calpastatin seems to be a highly conserved characteristic ( Figure  41 , particularly in the domains that possess inhibitory activity (Maki et al., 1987; Emori et al., 1988; Uemori et al., 1990) . Domain L, which lacks inhibitory activity but is thought to contain regulatory properties, shows much greater variability in hydropathic structure. It is possible that variability in domain L may alter selection of splice site, message, and product stability, resulting in regulation of calpastatin inhibitory activity. These variations may be characteristic of species, tissue, and physiological state.
Expression of Calpastatin mRNA. Numerous studies have reported effects of BAA on the components of the skeletal muscle calpain system. One of the most consistent effects of BAA feeding is the significant increase in calpastatin activity (Higgins et al., 1988; Wang and Beermann, 1988; Forsberg et al., 1989; Kretchmar et al., 1990; Koohmaraie et al., 1991; Wheeler and Koohmaraie, 1992; Pringle et al., 1993) . Two general levels of gene expression regulation that could possibly account for the reported increase in calpastatin activity are pre-and post-translational control. To determine whether pretranslational levels of calpastatin mRNA are increased with BAA treatment, the level of calpastatin mRNA was determined using cDNA probes homologous to bovine calpastatin.
The samples were obtained from two previous studies (Koohmaraie et al., 1991; Wheeler and Koohmaraie, 1992) . Those studies reported increases in LM area and extractable LM calpastatin activity (Table 2) . KOOHMARAIE The BAA treatment was found to increase the amount of total calpastatin mRNA in both beef and lamb to levels more than double those of their respective controls ( Table 2) . Discrepancies in the percentage increase of calpastatin mRNA levels (> 100%) and the activity levels (60%) may be attributable to BAAinduced isoform selection and its possible effects on translational efficiency and(or) product activity.
To determine whether the observed increase in total calpastatin mRNA was due to a general increase in all calpastatin mRNA isoforms or whether the different isoforms show varying responsiveness to BAA, Northern blots were run on the control and BAA samples and subjected to scanning densitometry. Results indicated that the calpastatin isoforms are independently regulated with respect to BAA (L644,969) stimulation (Figure 3 ). The BAA treatment was shown to increase the level of expression of the 3.0 and the 3.8 kb isoforms in beef, but of particular interest is the effect of BAA treatment on the ratio of the 3.0:3.8 kb isoforms. The ratio (3.0:3.8) is different between control and BAA treatment groups in both beef (control = .96 k .12, BAA = 1.48 k .14, P < .05) and aThe longissimus muscle area and calpastatin activity data were compiled from data previously reported (Koohmaraie et al., 1991; Wheeler and Koohmaraie, 1992) . One unit of calpastatin is defined as the amount that inhibits one unit of m-calpain activity.
bTotal calpastatin mRNA expression levels normalized to absorbance units/microgram of total RNA. Values were determined from the linear portion of individual slot blot standard curves. 32P-labeled probe was bovine calpastatin cDNA encoding domains 2 through 4 and the 3'-nontranslated region ( pBSA1).
CNumber of observations per treatment were 4 for beef and 8 for lamb.
lamb (control = .41 f .03, BAA = .50 k .03, P < .05).
These results are in general agreement with those reported for Friesian cattle (Parr et al., 1992) . The size discrepancies between our study and that of Parr et al. (1992) cannot be explained without h r t h e r experimentation.
To our knowledge, this is the first report of the complete sequence of bovine skeletal muscle calpastatin cDNA and selective isoform responsiveness to BAA-induced muscle hypertrophy.
Implications
Bovine skeletal muscle calpastatin cDNA probes have been cloned, sequenced, and analyzed, allowing for the development of cDNA probes that are compatible for use in both bovine and ovine studies. Calpastatin messenger RNA was demonstrated t o exist in multiple isoforms that were differentially effected by @-adrenergic agonist feeding. Complementary DNA probes to calpastatin will allow for examination of this gene's involvement in regulation of muscle protein degradation during growth and postmortem storage and its potential in marker-assisted selection.
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